Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs

Dades bibliogràfiques
Autors principals:	Sutanto, H, Laudy, L, Clerx, M, Dobrev, D, Crijns, H, Heijman, J
Format:	Journal article
Publicat:	Elsevier 2019

Ítems similars

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
per: Gheorghe-Andrei Dan, et al.
Publicat: (2018-12-01)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
per: Jordi Heijman, et al.
Publicat: (2013-08-01)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
per: Jordi Heijman, et al.
Publicat: (2013-01-01)

Interactions that matter: 10 Antiarrhythmic drugs
per: Aronson, J
Publicat: (1987)

Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
per: Keitaro Hashimoto
Publicat: (2007-01-01)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
per: Inseok Hwang, et al.
Publicat: (2021-05-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
per: A. A. Upnitskiy
Publicat: (2014-12-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
per: Nathalie Oeffl, et al.
Publicat: (2023-05-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
per: Joanne J. A. van Bavel, et al.
Publicat: (2018-02-01)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
per: Inseok Hwang, et al.
Publicat: (2022-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
per: V. L. Doshchitsin, et al.
Publicat: (2022-07-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
per: B. A. Tatarsky, et al.
Publicat: (2021-08-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
per: Marco Valerio Mariani, et al.
Publicat: (2024-08-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
per: Sean P. Gaine, et al.
Publicat: (2023-04-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
per: Ibrahim El-Battrawy, et al.
Publicat: (2019-08-01)

Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin
per: Ravshanbek D. Kurbanov, et al.
Publicat: (2019-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
per: Koichiro Kumagai, MD, et al.
Publicat: (2011-01-01)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
per: Xu Gao, et al.
Publicat: (2018-03-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
per: K. A. Skiba, et al.
Publicat: (2003-06-01)

Determination of the composition of pharmaceutical substances used in drugs with antiarrhythmic activity
per: A. V. Rogov, et al.
Publicat: (2024-01-01)

Electrocardiostimulation in acute poisoning with antiarrhythmic drugs in children (clinical case)
per: K. V. Pshenisnov, et al.
Publicat: (2023-02-01)

Crystal Structure of Novel Terephthalate Salt of Antiarrhythmic Drug Disopyramide
per: Majid Ismail Tamboli, et al.
Publicat: (2021-03-01)

Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
per: Takashi Komatsu
Publicat: (2012-06-01)

Efficiency of phencarol in combination with standard antiarrhythmic drugs in extrasystoles in children
per: O N Soldatova, et al.
Publicat: (2008-09-01)

ANTIARRHYTHMIC EFFECT OF PENTAMIN
per: Y. R. Sheykh-Zade, et al.
Publicat: (2001-02-01)

Statins and their antiarrhythmic activity
per: N. Sh. Zagidullin, et al.
Publicat: (1970-01-01)

Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic Drugs
per: Christian Ellermann, et al.
Publicat: (2025-02-01)

Analysis of fatal outcome structure in acute poisoning with hypotensive and antiarrhythmic drugs
per: K. K. Ilyashenko, et al.
Publicat: (2024-03-01)

Crystal Structures of Antiarrhythmic Drug Disopyramide and Its Salt with Phthalic Acid
per: Majid Ismail Tamboli, et al.
Publicat: (2021-04-01)

The Resurfacing of Bepridil Hydrochloride on the World Stage as an Antiarrhythmic Drug for Atrial Fibrillation
per: Yuji Nakazato, MD, PhD
Publicat: (2009-01-01)

Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs
per: E. A. Ushkalova, et al.
Publicat: (2016-11-01)

Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs
per: E. A. Ushkalova, et al.
Publicat: (2016-09-01)

The mechanism of drug interactions of a selected antiarrhythmic drug with metformin, in different animal models
per: Kayamkani Abedulla Khan, et al.
Publicat: (2018-01-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
per: V. I. Podzolkov, et al.
Publicat: (2015-09-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
per: V. I. Podzolkov, et al.
Publicat: (2015-09-01)

Effects of Antiarrhythmic Drugs on the Hyperpolarization-Activated Cyclic Nucleotide–Gated Channel Current
per: Atsushi Tamura, et al.
Publicat: (2009-01-01)

Electrical Restitution and Its Modifications by Antiarrhythmic Drugs in Undiseased Human Ventricular Muscle
per: Tamás Árpádffy-Lovas, et al.
Publicat: (2020-04-01)

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden
per: Gheorghe-Andrei Dan
Publicat: (2020-08-01)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
per: Jonathan G. Tardos, et al.
Publicat: (2021-03-01)

Ablation and antiarrhythmic drug effects on PITX2+/− deficient atrial fibrillation: A computational modeling study
per: Ze Jin, et al.
Publicat: (2022-07-01)